Go to deals
Healthcare | Private Equity

Empirical Bioscience has been acquired by Fortis Life Sciences

The owner of Empirical Bioscience has sold the company to Fortis Life Sciences.

Empirical Bioscience is a leading developer and manufacturer of enzymes, proteins and reagents for molecular biology and life science applications. Empirical focuses on supplying premium, quality and custom-configured products to the life sciences industry for both research and commercial applications. The company has a comprehensive library of products that can be readily configured to customer specifications and offers technical support to assist with the development and launch of assays and products.

Fortis Life Sciences is a strategic platform providing capital, expertise and operational resources enabling the growth and success of founder-led life science tools companies.

One of Oaklins’ teams in the USA served as the financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences.

Parties

Talk to the deal team

 Bradford A. Adams

Bradford A. Adams

Managing Director
Boston, United States
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital
 Harrison P. Boeschenstein

Harrison P. Boeschenstein

Associate
Boston, United States
Oaklins TM Capital

Related deals

Top Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider
Private Equity | Energy

Top Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider

Holland Capital, a Netherlands-based private equity firm, has acquired a stake in Top Systems, a leading provider of complete battery-based power solutions, with a unique value-added services proposition.

Learn more
Infotreasury has been sold to Matera
Private Equity | Financial Services | TMT

Infotreasury has been sold to Matera

Matera, a leading banking software company with world-class instant payments and core banking solutions, has acquired Infotreasury.

Learn more
Thrive Freeze Dry has successfully sealed the acquisition deal with Paradiesfrucht GmbH
Private Equity | Food & Beverage

Thrive Freeze Dry has successfully sealed the acquisition deal with Paradiesfrucht GmbH

Paradiesfrucht GmbH, a gobal freeze dryer of fruits, fruit preparations, drops, powders and granulates, has been acquired by Thrive Freeze Dry (Thrive), a portfolio company of Entrepreneurial Equity Partners (e2p) and Mubadala Capital. The transaction is expected to close in 2024, subject to customary closing conditions, including antitrust approval.

Learn more